Axon - Brain Train for Pain

Axon - Brain Train for Pain - A Home-based Neurofeedback Intervention to Treat the Primary and Secondary Symptoms of Chronic Pain

A mixed methods proof of concept study to ascertain the effectiveness of a home-based self-administered neurofeedback intervention to treat the primary and secondary symptoms of chronic pain.

Study Overview

• Status: Completed
• Conditions: Quality of Life; Chronic Pain; Sleep; Depression, Anxiety
• Intervention / Treatment: Other: Neurofeedback training

Detailed Description

In order to address the growing problem of chronic pain management in the UK, a proof of concept/feasibility open label study has been devised to test a home-based self-administered non-pharmacological treatment utilising neurofeedback training with a headset and tablet-based software application.

This study will include individuals suffering from various types of chronic pain, measuring changes in pain intensity alongside associated symptoms (depression, anxiety, sleep, and quality of life) by utilising a purpose-built software application and headset that is easy to use and structurally robust.

Twenty participants will take part in pre-intervention quantitative assessments measuring the primary and secondary symptoms of chronic pain. This will be followed by one-to-one remote training where they will be provided with detailed instructions on how to self-administer the neurofeedback training in the comfort of their own homes. They will then take part in 4-6 training sessions per week over an 8-week period.

Post- intervention quantitative assessments will be conducted alongside a qualitative analysis of the experience of doing neurofeedback training for chronic pain. Participant feedback on how the protocol, equipment and research could be improved will also be recorded to inform further research.

Participants will also take part in online follow-up assessments at 1, 3, and 6 months after the intervention. Any adjustments to pain medication will also be recorded over this period. It is anticipated this study will provide initial evidence of the safety, efficacy, reliability and validity of a low-cost non-pharmacological solution to the physical, psychological and social difficulties experienced by individuals with chronic pain, with a view to a larger subsequent multisite trial.

• Study Type: Interventional
• Enrollment (Actual): 20
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Northampton, United Kingdom
    • East Midlands Spine Ltd

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Head circumference range (560 - 595 mm)
• Patients suffering from chronic pain (mean VNS >4) for at least 6 months.
• Chronic pain from any neurological or musculoskeletal cause, of which examples could be, post herpetic (or post-shingles) neuralgia, complex regional pain syndrome (CRPS), lower back pain, neck pain, major joint pain, spinal cord injury, phantom limb pain, brachial plexus injury related pain, traumatic peripheral nerve injury pain and post-cancer treatment pain
• Stable medication and treatment over the intervention period
• Participant or caregiver with minimum computer literacy able to effectively operate equipment after training, and the ability to position and remove headset effectively for training sessions

Exclusion Criteria:

• Patients who do not meet inclusion criteria (above)
• Failing pre-screening suitability criteria for neurofeedback due to a neurological disorder, psychiatric disorder, epilepsy, regular use of benzodiazepines, previous neurofeedback training, serious head injury and other medication that has contraindications for neurofeedback training
• Dreadlocks, braids, beads, or any other hairstyle or hair covering that cannot be removed for training
• Known or suspected pregnancy
• Diagnosis of (or currently undergoing treatment for) cancer, systemic infection, severe cardiovascular/respiratory comorbidity
• Implanted electronic neuromodulation device
• Implanted pacemaker or loop recorder
• Any change in medication or treatment planned during the intervention period
• Inability to use the equipment due to severity of pain

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Neurofeedback training; Neurofeedback training: self-administered at home 4-6 times per week for 8 weeks. Each session consists of 6 blocks of 5 minute training with a one minute rest period between each block.	Other: Neurofeedback training; A home-based self-administered neurofeedback intervention taking place 4-6 times per week for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in pain intensity as measured by the VNS (Visual Numerical Scale)	Ordinal measurement of individual's pain intensity	Pre-intervention, before and after each training session over 8 week period, and 1, 3 and 6 months after final training session

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in mood as measured by Hospital Anxiety and Depression Scale (HADS)	Rating scale (self-administered)	Pre-intervention, after the final training session (8 weeks), and 1, 3 and 6 months after final session
Change in quality of sleep as measured by the Pittsburgh Sleep Quality Index (PSQI)	A self-report questionnaire assessing sleep quality	Pre-intervention, after the final training session (8 weeks), and 1, 3 and 6 months after final session
Change in quality of life components as measured by the EQ-5D-5L	A self-assessed, health related, quality of life questionnaire.	Pre-intervention, after the final training session (8 weeks), and 1, 3 and 6 months after final session
Changes in EEG activity	Changes in relative Alpha, Theta and Beta ratio, as measured by EEG	Baseline (eyes open and eyes closed) pre-intervention, and before and after each training session over 8 weeks
Experience of chronic pain and neurofeedback training	Qualitative interviews of the lived experience of taking part in neurofeedback training for chronic pain	Post-intervention - after final training session (8 weeks)

Collaborators and Investigators

• Sponsor: Exsurgo Rehab Limited
• Collaborators: East Midlands Spine Ltd; PhysioFunction Ltd
• Investigators: Principal Investigator: Nicholas Birch, East Midlands Spine Ltd

Publications and helpful links

General Publications

• Birch N, Graham J, Ozolins C, Kumarasinghe K, Almesfer F. Home-Based EEG Neurofeedback Intervention for the Management of Chronic Pain. Front Pain Res (Lausanne). 2022 May 27;3:855493. doi: 10.3389/fpain.2022.855493. eCollection 2022.

Study record dates

Study Major Dates

• Study Start (Actual): June 16, 2020
• Primary Completion (Actual): January 31, 2021
• Study Completion (Actual): July 28, 2021

Study Registration Dates

• First Submitted: May 29, 2020
• First Submitted That Met QC Criteria: June 3, 2020
• First Posted (Actual): June 5, 2020

Study Record Updates

• Last Update Posted (Actual): March 23, 2022
• Last Update Submitted That Met QC Criteria: March 21, 2022
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Chronic Pain
• Other Study ID Numbers: ED1001033

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No